Login
Companies $ARE
$43.40 +$0.38 (0.88%) Close
Alexandria Real Estate Equities, Inc logo

Alexandria Real Estate Equities, Inc

are.com

What Do They Do?

Owns, develops, and leases laboratory buildings to pharmaceutical and biotechnology companies and research institutions.

How Do They Make Money?

Rental income comes from tenants paying to use the company's properties; short-term parking revenue is earned when the parking service is provided.

revenue
SegmentShareRevenue
Income from rentals
Recurring

97%
FY2022: 100%
Other income
2.7%
FY2022: 0.5%

Who Are Their Customers?

Tenants include pharmaceutical and biotechnology companies, other life-science businesses, and academic, medical, and government research organizations.

Do Revenues Turn Into Profits?

No. It lost $1.4B in FY2025.

Net income, FY2025
−47% of revenue
▼ Now a loss vs FY2024 ($322.9M, 10%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Revenue
▼ −11%
vs $751.9M in Q3 FY2025
Net income
▲ +174% (Loss)
vs −$232.8M in Q3 FY2025

Growing. Revenue grew 43% in 4 years, from $2.1B in FY2021 to $3B in FY2025, about 9% a year.

Laboratory space Development descriptions move from office/laboratory, agtech, and technology space to ground-up laboratory facilities and conversions of office, warehouse, or shell space into laboratory space.

Venture investments The latest report describes non-real-estate investments as primarily in life science entities; the older report also named agtech, agrifoodtech, climate innovation, and technology entities.

Revenue over time
Income from rentals Other income
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support